20+ products and patient care programs, covering all solid tumors
with business coverage
we served each year
3DMed clinical laboratory was established in October 2015, mainly focusing on molecular diagnostic in terms of laboratory developed test (LDT) business. Since its establishment, the laboratory has always adhered to the principle of quality first, and established a laboratory quality management system in accordance with international standards such as the College of American Pathologists (CAP) and ISO15189. Since 2016, it has passed the external quality assessment（EQA）of international ( CAP and EMQN) and domestic (National Health Commission and Shanghai Center for Clinical laboratory) for 50 consecutive times
The laboratory passed the CAP on-site review on December 7, 2017, and passed the CLIA certification on May 22, 2019, which indicates that the quality system and the reports issued by 3DMed clinical laboratory have been recognized globally.